The global industrial robotics market was valued at US$ 18.53 Bn in 2019, expanding at a CAGR of 12.1% during the forecast period from 2020 to 2028. The accelerating pace of automation is transforming a widening range of industries. Therefore, robots have made their way and are spreading throughout warehouses and manufacturing facilities around the world.
The global pneumococcal vaccines market held US$ 7,108.7 Mn in 2020 and expected to grow at compound annual growth rate (CAGR) of 5.1% during the forecast period from 2021 to 2029. Pneumococcal diseases are one of the leading cause of serious illness globally resulting in high number of hospitalization every year.
Anti-aging devices market accounted for a market value of US$ 25,637.1 Mn in 2020 and projected to grow at a CAGR of 8.6% during the forecast period from 2021 to 2029. Anti-aging devices industry is changing gradually mainly assisted by increasing public awareness through promotional media and product accessibility through online sales channel.
The global endotoxin testing market is developing significantly with an expected CAGR of 8.5% from 2019 - 2029. Advances in technological processes are the key growth factor. For example: Limulus Amebocyte Lysate (LAL) test has been recommended by European and American pharmacopeia to identify bacterial endotoxins in the drugs through LAL test. This method was introduced in 1960s however, introduction on various kinds of reagents, kits and devices have simplified the process, thereby increasing the revenues and creating significant opportunities. The impact of covid 19 was severe in healthcare, though this market is not directly related to healthcare delivery institution, however, struggled due to pause on clinical trials across pharma and medical devices during the pandemic.
Growing adoption of minimally invasive procedures and enhanced safety profile of cryoablation and cryotherapy are the key factors that are determining the overall trends in the global cryotherapy devices market. These factors have led to increased adoption of cryotherapy devices in cardiology, renal conditions, pain management and tumor removal. Cryotherapy mainly involved administration through very low temperatures in surgery and chambers. Agents such as carbon dioxide, argon, liquid nitrogen and dimethyl ether propane are extensively employed in cryotherapy applications.
The growth in demand for sterilization indicators is expected to be driven by growing emphasis on refurbishing and reprocessing of medical devices for tackling the growing healthcare expenses and increasing demand for safe food and drugs.
The global medical courier market is growing steadily as a direct effect of the rising trends in the same day delivery and express delivery segment. Expansion of healthcare transportation/logistics and growing demand for faster delivery of samples and specimens for diagnostic or testing purposes generates maximum revenue share in the market.
The global high throughput screening (HTS) market is growing effectively, valued at US$ 16.01 Bn in 2020 and estimated to reach US$ 29.59 Bn by 2029. Increasing need for drug discovery in pharmaceuticals & biotechnology will enhance the overall expansion of high throughput screening market globally. New technology assessment in the field of cell based assays is significant; the fluorometric imaging plate reader cell based assays will drive the market in developed nations. New automated platforms for ultra high throughput screening will gain traction globally.
The dilated cardiomyopathy therapeutics market is set to reach US$ xx Mn by 2033 from US$ xx Mn in 2021 featuring magnificent growth at a compounded annual growth rate (CAGR) of 4.7% during the forecast period from 2025 to 2033. As per the latest research citings of World Health Organization (WHO), annually 17.9 million people die throughout the globe from cardiovascular diseases which is equivalent o 31% of all global deaths. Factors responsible for congestive heart failure are sedentary lifestyle, obesity, unhealthy lifestyle and congenital heart complications.
The global chromatography systems market is growing fruitfully, valued at US$ 7.5 Bn in 2020 and expected to reach US$ 13.79 Bn by 2029. Worldwide increasing need for separation analysis in pharmaceuticals, environmental/water, biotechnology, food & agriculture applications will enhance the overall growth of the chromatography systems globally.
The drugs by therapeutic area market covers pharmaceutical products classified according to the diseases and medical conditions they are designed to treat. Major therapeutic areas include oncology, cardiovascular diseases, diabetes and other metabolic disorders, neurological conditions, infectious diseases, respiratory disorders, immunology, gastrointestinal diseases, dermatology, ophthalmology, women’s health and rare diseases. The category includes prescription drugs, generic medicines, biologics, biosimilars, vaccines and advanced therapies.
The wider global pharmaceutical market provides an appropriate benchmark for evaluating growth across therapeutic drug categories. One current industry estimate projects the pharmaceutical market to increase from approximately USD 1.88 trillion in 2026 to USD 3.22 trillion by 2035, representing a compound annual growth rate of 6.15%. North America held the largest regional share in 2025, while Asia-Pacific is expected to demonstrate notable growth through 2035.
Market growth is being supported by the increasing prevalence of chronic and age-related diseases. Rising cases of cancer, diabetes, cardiovascular disorders, arthritis, respiratory diseases and neurological conditions are creating sustained demand for effective treatments. Population ageing, lifestyle changes, urbanization and improved access to diagnosis are further expanding the number of patients receiving long-term therapy.
Oncology remains an important area for pharmaceutical research and commercial investment. Development activity includes targeted therapies, immune checkpoint inhibitors, antibody-drug conjugates, cell therapies and personalized cancer treatments. Diabetes and obesity drugs are also recording strong demand, supported by the wider use of GLP-1 and other metabolic treatments. Neurology research is expanding across Alzheimer’s disease, Parkinson’s disease, epilepsy and mental health conditions.
Biologic drugs and biosimilars represent major market trends. Biologics are increasingly used to treat cancer, autoimmune diseases and rare disorders, while biosimilars can improve access after reference-product patent expiry. Pharmaceutical companies are also developing gene therapies, RNA-based medicines and other advanced treatments for conditions with limited existing options.
Precision medicine is influencing drug development across multiple therapeutic areas. Biomarkers, genomic testing and companion diagnostics help identify patients who are more likely to respond to specific medicines. Artificial intelligence is also being used for target identification, clinical-trial planning and analysis of real-world treatment data.
Market expansion may be restrained by high research costs, lengthy clinical development, regulatory uncertainty and drug-pricing pressure. Patent expirations can reduce revenue for branded products, while safety concerns or unsuccessful clinical trials may delay commercial launches. Access and reimbursement remain major challenges for expensive biologics and advanced therapies.
Acute Market Reports provides therapeutic-area drug research covering product classes, disease indications, routes of administration, distribution channels, company pipelines, competitive conditions and regional opportunities. These reports help pharmaceutical companies, investors, healthcare providers and distributors evaluate treatment demand and growth prospects through 2035.